Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Study to Predict Optimised Treatment Response to Short or Long Acting Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder.

NCT00863499 is registered in ClinicalTrials.gov with BRC Operations Pty. Ltd. as lead sponsor.

NCT NCT00863499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00863499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Study to Predict Optimised Treatment Response to Short or Long Acting Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder.
Lead sponsor
BRC Operations Pty. Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2009
Completion date
December 31, 2019
Enrollment
1,344 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit/hyperactivity disorder